BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19594886)

  • 1. Energy profile and secondary structure impact shRNA efficacy.
    Zhou H; Zeng X
    BMC Genomics; 2009 Jul; 10 Suppl 1(Suppl 1):S9. PubMed ID: 19594886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of duplex stability and terminal asymmetry for shRNA design.
    Matveeva OV; Kang Y; Spiridonov AN; Saetrom P; Nemtsov VA; Ogurtsov AY; Nechipurenko YD; Shabalina SA
    PLoS One; 2010 Apr; 5(4):e10180. PubMed ID: 20422034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of target secondary structure on RNAi efficiency.
    Shao Y; Chan CY; Maliyekkel A; Lawrence CE; Roninson IB; Ding Y
    RNA; 2007 Oct; 13(10):1631-40. PubMed ID: 17684233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quick and efficient approach for gene silencing by using triple putative microRNA-based short hairpin RNAs.
    Shan ZX; Lin QX; Yang M; Deng CY; Kuang SJ; Zhou ZL; Xiao DZ; Liu XY; Lin SG; Yu XY
    Mol Cell Biochem; 2009 Mar; 323(1-2):81-9. PubMed ID: 19037714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. shRNAs targeting hepatitis C: effects of sequence and structural features, and comparision with siRNA.
    Vlassov AV; Korba B; Farrar K; Mukerjee S; Seyhan AA; Ilves H; Kaspar RL; Leake D; Kazakov SA; Johnston BH
    Oligonucleotides; 2007; 17(2):223-36. PubMed ID: 17638526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structural interpretation of the effect of GC-content on efficiency of RNA interference.
    Chan CY; Carmack CS; Long DD; Maliyekkel A; Shao Y; Roninson IB; Ding Y
    BMC Bioinformatics; 2009 Jan; 10 Suppl 1(Suppl 1):S33. PubMed ID: 19208134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNAi Codex: a portal/database for short-hairpin RNA (shRNA) gene-silencing constructs.
    Olson A; Sheth N; Lee JS; Hannon G; Sachidanandam R
    Nucleic Acids Res; 2006 Jan; 34(Database issue):D153-7. PubMed ID: 16381835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of simple and efficient DNA vector-based short hairpin RNA expression systems for specific gene silencing in mammalian cells.
    Cheng TL; Chang WT
    Methods Mol Biol; 2007; 408():223-41. PubMed ID: 18314586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. shRNA expression constructs designed directly from siRNA oligonucleotide sequences.
    Barøy T; Sørensen K; Lindeberg MM; Frengen E
    Mol Biotechnol; 2010 Jun; 45(2):116-20. PubMed ID: 20119685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An RNA polymerase II construct synthesizes short-hairpin RNA with a quantitative indicator and mediates highly efficient RNAi.
    Zhou H; Xia XG; Xu Z
    Nucleic Acids Res; 2005 Apr; 33(6):e62. PubMed ID: 15805121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and validation of siRNAs and shRNAs.
    Tilesi F; Fradiani P; Socci V; Willems D; Ascenzioni F
    Curr Opin Mol Ther; 2009 Apr; 11(2):156-64. PubMed ID: 19330721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of extended short hairpin RNAs for HIV-1 inhibition.
    Liu YP; Haasnoot J; Berkhout B
    Nucleic Acids Res; 2007; 35(17):5683-93. PubMed ID: 17715143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An RNAi in silico approach to find an optimal shRNA cocktail against HIV-1.
    Méndez-Ortega MC; Restrepo S; Rodríguez-R LM; Pérez I; Mendoza JC; Martínez AP; Sierra R; Rey-Benito GJ
    Virol J; 2010 Dec; 7():369. PubMed ID: 21172023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the optimal parameters for hairpin-based knockdown constructs.
    Li L; Lin X; Khvorova A; Fesik SW; Shen Y
    RNA; 2007 Oct; 13(10):1765-74. PubMed ID: 17698642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation and application of a bovine U6 promoter for expression of short hairpin RNAs.
    Lambeth LS; Moore RJ; Muralitharan M; Dalrymple BP; McWilliam S; Doran TJ
    BMC Biotechnol; 2005 May; 5():13. PubMed ID: 15885150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiling genomes of pathogenic viruses identifies potent antiviral shRNAs and reveals a role for secondary structure in shRNA efficacy.
    Tan X; Lu ZJ; Gao G; Xu Q; Hu L; Fellmann C; Li MZ; Qu H; Lowe SW; Hannon GJ; Elledge SJ
    Proc Natl Acad Sci U S A; 2012 Jan; 109(3):869-74. PubMed ID: 22219365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors.
    Fish RJ; Kruithof EK
    BMC Mol Biol; 2004 Aug; 5():9. PubMed ID: 15291968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of shRNA inhibitors by variation of the terminal loop sequence.
    Schopman NC; Liu YP; Konstantinova P; ter Brake O; Berkhout B
    Antiviral Res; 2010 May; 86(2):204-11. PubMed ID: 20188764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short hairpin RNA (shRNA): design, delivery, and assessment of gene knockdown.
    Moore CB; Guthrie EH; Huang MT; Taxman DJ
    Methods Mol Biol; 2010; 629():141-58. PubMed ID: 20387148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for the optimal design of miRNA-based shRNAs.
    Bofill-De Ros X; Gu S
    Methods; 2016 Jul; 103():157-66. PubMed ID: 27083402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.